Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospekta in vascular dementia
NCT04552041Phase 3Completed
- Sponsor
- Materia Medica Holding
- Start
- Dec 2020
- Primary completion
- Sep 2022
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of Prospekta in vascular dementia, sponsored by Materia Medica Holding. Started Dec 2020; status: completed.
02
Drugs
Prospekta
03
Conditions
vascular dementia
Beyond the preview
Go deeper on NCT04552041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04552041.